Raise closed, search for fresh raises on Seedstage

Irvine, CA

Developing innovative imaging technology to enhance diagnostic capabilities and patient safety in healthcare.

• Mission: Revolutionizing medical imaging with the development of Meta CT technology, designed to replace traditional imaging systems and enhance diagnostic accuracy while reducing radiation exposure.  
• Innovation: Creating the first Meta CT technology, which delivers high-resolution, high-accuracy images, improving patient safety and diagnostic efficiency.  
• Healthcare Impact: Aiming to improve patient outcomes by providing advanced imaging solutions that enhance the ability to diagnose and treat life-threatening and chronic diseases.  
• Market Opportunity: Positioned to address the growing demand for advanced medical imaging technology in a rapidly expanding market.  
• Technology: Leveraging cutting-edge optical technology to deliver precise and detailed imaging, with a focus on eco-friendly and affordable solutions for healthcare providers.  
• Leadership and Partnerships: Led by a team of industry experts and supported by strategic partnerships with OEMs, sales partners, and service providers, strengthening its ability to bring transformative solutions to the healthcare sector.  
• Patient-Centered Approach: Committed to improving quality of life and supporting independence for individuals impacted by illness through advanced diagnostic tools.

XENSE is on a mission to revolutionize medical imaging by developing the first Meta CT technology, which aims to replace traditional imaging systems like toroid CT and general x-ray machines. This innovative technology is designed to provide high-resolution and high-accuracy images while significantly reducing radiation exposure, thereby enhancing patient safety and diagnostic efficiency.

Targeting the substantial medical imaging market, which is projected to grow significantly, XENSE is poised to meet the increasing demand for advanced imaging solutions. The company is currently in the pre-sales and pre-revenue stage, working diligently to bring its products, UTOMO™ and META™, to market.

By joining this initiative, investors can be part of a transformative approach to healthcare that not only improves imaging capabilities but also contributes to better patient outcomes. With a strong team of industry experts and a clear vision for the future, XENSE aims to set new standards in healthcare delivery and medical imaging technology, ultimately improving quality of life for patients worldwide.

Company Info

Xense develops advanced imaging and therapeutic tools to improve diagnostics and patient care.

Xense is a company dedicated to transforming the field of medical imaging by developing advanced, eco-friendly, and affordable imaging and therapeutic tools. With a mission to enhance the ability to diagnose and treat life-threatening and chronic diseases, Xense leverages innovative optical technology to deliver precise, detailed, and large-scale imaging solutions. The company’s goal is to improve patient outcomes, extend quality of life, and support independence for individuals impacted by illness.

Xense’s leadership team consists of experts in medical affairs, technology, and regulatory affairs, working together to bring cutting-edge solutions to the healthcare industry. The company’s partnerships with OEMs, sales partners, and service providers further enhance its capabilities, making it a trusted partner in the global mission to improve life conditions.